BENITEC BIOPHARMA INC.

3940 TRUST WAY

HAYWARD, CALIFORNIA 94545

May 29, 2025

VIA EDGAR

Jason Drory

Securities and Exchange Commission

Division of Corporation Finance

Office of Life Sciences

100 F Street, N.E.

Washington, D.C. 20549

 

Re:	Benitec Biopharma Inc.

Registration Statement on Form S-3 (File No. 333-287566)

Dear Mr. Drory:

Pursuant to Rule 461 of the Securities Act of 1933, as amended, Benitec Biopharma Inc. hereby requests acceleration of the effective date of the above-referenced Registration Statement on Form S-3 (File No. 333-287566) so that it may become effective at 4:00 p.m. Eastern Time on June 2, 2025, or as soon thereafter as practicable.

 

 

 

cc:	Matt O’Loughlin, Proskauer Rose LLP

Louis Rambo, Proskauer Rose LLP